retatrutide type 2 diabetes trial results Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care Eli Lilly just announced striking
Description
doi: 10.4103/1673-5374.332122
We know that obesity and diabetes impact reproduction for both women and men, and that improving body composition and insulin sensitivity positively impact fertility
10.1208/s12248-015-9854-1 98
Gariballa SE, Al-Bluwi G, Yasin J
Trials for Retatrutide use different designs, doses, and timeframes compared with older studies, so direct comparisons are not straightforward
In addition, the results were similar for subgroup analysis by diabetes status
